Tuesday 10 November 2020

The Brewery, London EC1

2020 Shortlist review

Back | Best Communication Award | Breakthrough of the Year AwardBest Technology Award
Mediscience Commentator of the Year Award | Capital Market Transaction of the Year Award
Most Significant Contribution to the Mediscience Sector Award The Emerging Star Award
Chief Executive of the Year Award | Company of the Year Award 


Mediscience Commentator of the Year Award

Sponsored by Instinctif Partners

Criteria 

This award recognises the importance of clear and concise commentary on the sector. It could be awarded to a journalist, a columnist, a research house, a specialist website or a team that is dedicated to providing sharp, perceptive and penetrating commentary about the sector.

In-depth knowledge of the sector is a given; the Voting Panel will be looking for excellence in the way that knowledge is communicated to the wider audience.

The 2020 finalists:  


EMA20_Shortlist-commentator_L.Ellis_InVivo.png

Lucie Ellis/In Vivo 

www.invivo.pharmaintelligence.informa.com/authors/lucie-ellis 

Lucie is the Executive Editor of In Vivo, an Informa Pharma Intelligence publication providing specialist insight and analysis for the pharmaceutical, medtech and diagnostics sectors.

In Vivo provides comprehensive industry analysis to help inform corporate strategies. It was highlighted by the Voting Panel as being a trusted source of lifescience information and analysis, and Lucy, in particular, plays a vital role in contributing to this.

Lucie is an experienced sector commentator, having covered the ups and downs of the pharmaceutical industry since joining the Informa Pharma Intelligence team in 2012. Prior to In Vivo, Lucie was a Senior Editor at Scrip and Pink Sheet where she gained vast experience covering the biopharma and medtech markets. 

 

 
EMA20_Shortlist-commentator_SHansen_BioCentury.png

Stephen Hansen/BioCentury 

www.biocentury.com

Stephen is Associate Editor at BioCentury, where he serves as a primary point of contact with European companies and investors.

Stephen is well known and well connected in the industry and it was noted by the Voting Panel that his writing does a proficient job of covering both financial and scientific viewpoints.

Stephen has covered clinical development, corporate strategy and finance in Europe, the US and China for over a decade and is a frequent contributor to BioCentury’s quarterly Financial Markets Preview and annual Buyside View and European Finance reports.

 
EMA20_Shortlist-commentator_SMeddings_SundayTimes.png 

Sabah Meddings/The Sunday Times 

www.thetimes.co.uk

Sabah is a Business Reporter at the Sunday Times, reporting on some of the biggest stories in the pharmaceuticals and Life Sciences sectors.

Sabah’s work has included analysis of the strategy of large pharma, along with trends driving development, funding and innovation in smaller companies and university spin outs. Sabah is keen to make Life Sciences accessible to a general audience because she believes raising the profile of the sector is key to ensuring it receives the attention of government and international investors. 

Prior to the Sunday Times, Sabah was a City Correspondent at the Daily Mail, where she wrote across all sectors. 

 

 
EMA20_Shortlist-commentator_NMoran_BioCentury.png

Nuala Moran/BioWorld 

www.bioworld.com

Nuala Moran is a Freelance Science Journalist and has been part of the BioWorld team since 1996.

Nuala is a passionate advocate for the lifescience sector and is considered to be one of Europe's most experienced science and technology journalists. She recently extended her remit to cover medtech and the Voting Panel commented on Nuala’s extensive coverage of the scientific and commercial development of the biotechnology sector in Europe and the US

Nuala was formerly Managing Editor of science journal, Nature,and, prior to this, was Innovation Editor of The Independent on Sunday and also Deputy Editor of Computer Weekly.